supported by the National Natural Science Foundation of China(No.82274512);Guangzhou Science and Technology Project(No.202201020327);Collaborative basic and clinical Innovation project between Guangdong Hospital of Chinese Medicine and the School of Biomedical Sciences of the Chinese University of Hong Kong(No.YN2018HK02);Guangdong basic and Applied basic Research Fund(No.2023A1515110708).
Prostate cancer(PCa)is the second most common malignancy among men globally.The Fu-Zheng-Yi-Liu(FZYL)Formula has been widely utilized in the treatment of PCa.This study investigates whether the FZYL Formula can inhibi...